References
- Szilvassy SJ. The biology of hematopoietic stem cells. Arch Med Res 2003; 34: 446–60
- Bonnet D. Haematopoietic stem cells. J Pathol 2002; 197: 430–40
- Lakshmipathy U, Verfaillie C. Stem cell plasticity. Blood Rev 2005; 19: 29–38
- Bonnet D. Normal and leukaemic stem cells. Br J Haematol 2005; 130: 469–79
- Baron F, Storb R, Little M-T. Hematopoietic cell transplantation: five decades of progress. Arch Med Res 2003; 34: 528–44
- Freshney MG. Colony-forming assays for CFC-GM, BFU-E, CFC-GEMM, and CFC-Mix. Culture of Hematopoietic Cells, RI Freshney, IB Pragnell, MG Freshney. Wiley-Liss, USA 1994; 265–8
- Sutherland HJ, Eaves CJ. Long-term culture of human myeloid cells. Culture of Hematopoietic Cells, RI Freshney, IB Pragnell, MG Freshney. Wiley-Liss, USA 1994; 139–62
- Miller CL, Audet J, Eaves CJ. Ex vivo expansion of human and murine hematopoietic stem cells. Hematopoietic Stem Cell Protocols, CA Klug, CT Jordan. Humana Press, USA 2002; 189–208
- Douay L. Experimental culture conditions are critical for the ex vivo expansion of hematopoietic cells. J Hematother Stem Cell Res 2001; 10: 341–6
- Piacibello W, Sanavio F, Garetto L, et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997; 89: 2644–53
- Pecora AL. Progress in clinical applications of progenitor cells expanded with hematopoietic growth factors. Curr Opin Hematol 2001; 8: 142–8
- Haylock, DN, Simmons, PJ, Whitty, G et al. Ex-vivo expanded CD34+ cells enhance neutrophil and platelet recovery following multi-cycle high dose chemotherapy for metastatic breast cancer. Abstract, Cytotherapy. 2003;5:468.
- Shpall EJ, Quinones R, Giller R, et al. Transplantation of ex vivo expanded cord blood cells. Biol Blood Marrow Transplant 2002; 8: 368–76
- Jaroscak J, Goltry K, Smith A, et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase I trial using the Aastrom-Replicell System. Blood 2003; 101: 5061–7
- Wognum AW, Eaves EC, Thomas TE. Identification and isolation of hematopoietic stem cells. Arch Med Res 2003; 34: 461–75
- McNiece IK, Almeida-Porada G, Shpall EJ, et al. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. Exp Hematol 2002; 30: 612–16
- Lewis ID, Almeida-Porada G, Du J, et al. Umbilical cord blood cells capable of engrafting in primary, secondary and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system. Blood 2001; 97: 3441–9
- Flores-Guzman P, Flores-Figueroa E, Martinez-Jaramillo G, Mayani H. In vitro characterization of two lineage-negative CD34+ cell-enriched hematopoietic cell populations from human UC blood. Cytotherapy 2005; 7: 334–44
- Martinez-Jaramillo G, Flores-Guzman P, Montesinos JJ, et al. In vitro proliferation and expansion of hematopoietic progenitors present in mobilized peripheral blood from normal subjects and cancer patients. Stem Cells Dev 2004; 13: 382–9
- Hoffman R. Progress in the development of systems for in vitro expansion of human hematopoietic stem cells. Curr Opin Hematol 1999; 6: 184–91
- Zinzar S, Den T, Ohnuma T. Role of mononuclear cells in the regulation of hematopoiesis in fetal bone marrow and liver. Ann NY Acad Sci 1991; 628: 188–9
- Groendorst GR, Smale G, Pencev D. Production of transforming growth factor β by human peripheral blood monocytes and neutrophils. J Cell Physiol 1989; 140: 396–402
- Sautois B, Fillet G, Beguin Y. Comparative cytokine production by in vitro stimulated mononucleated cells from cord blood and adult blood. Exp Hematol 1997; 25: 103–8
- Bluman EM, Bartynski KJ, Avalos BR, Caligiuri MA. Human natural killer cells produce abundant macrophage inflammatory protein-1α in response to monocytes-derived cytokines. J Clin Invest 1996; 97: 2722–7
- Cluitmans FH, Esendam BH, Landegent JE, et al. Constitutive in vivo cytokine and hematopoietic growth factor gene expression in the bone marrow and peripheral blood of healthy individuals. Blood 1995; 85: 2038–44
- Morrison SJ, Shah NM, Anderson DJ. Regulatory mechanisms in stem cell biology. Cell 1997; 88: 287–98
- Mayani H. A glance into somatic stem cell biology: basic principles, new concepts and clinical relevance. Arch Med Res 2003; 34: 3–15
- Mayani H, Guilbert LJ, Janowska-Wieczorek A. Biology of the hemopoietic microenvironment. Eur J Haematol 1992; 49: 225–33
- Mackin W, Gunter KC, Kraus M. The frontier of cellular medicine: expanding umbilical cord blood stem cells for clinical use. Cancer J 2001; 7(suppl 2)S95–S105
- Madlambayan GJ, Rogers I, Kirouac DC, et al. Dynamic changes in cellular and microenvironmental composition can be controlled to elicit in vitro human hematopoietic stem cell expansion. Exp Hematol 2005; 33: 1229–39
- Engelhardt M, Kumar R, Albanell J, et al. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 1997; 90: 182–93
- Harrison D, Stone M, Astle CM. Effects of transplantation on the primitive immunohematopoietic stem cell. J Exp Med 1990; 172: 431–7
- Xu R, Reems JA. Umbilical cord blood progeny cells that retain a CD34+ phenotype after ex vivo expansion have less engraftment potential than unexpanded CD34+ cells. Transfusion 2001; 41: 213–18
- Lansdorp PM, Dragowska W, Mayani H. Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 1993; 178: 787–91
- Gardner RV, Lerner C, Astle CM, Harrison DE. Assessing permanent damage of primitive hematopoietic stem cells after chemotherapy using the competitive repopulation assay. Cancer Chemother Pharmacol 1993; 32: 450–4
- De Bruyn C, Delforge A, Martiat P, Bron D. Ex vivo expansion of neutrophil precursor cells from mobilized peripheral blood cells: similar results in cancer patients and normal donors. Cytotherapy 2005; 7: 470–7